1887

Abstract

Between 1986 and 1988, multiresistant strains exhibiting high-level cefotaxime resistance were isolated from patient specimens particularly of the intensive care units of the Aachen Technical University Hospital. The resistance gene responsible was shown to be encoded on a conjugative 66 kb plasmid designated pZMPI. The MIC values for cefotaxime of the original isolates and the transconjugants were > 128 mg I and 64 mg I. respectively, Isoelectric focusing of protein preparations from the transconjugants showed a β-lactamase with a pl of 7.6. A 3.6 kb Hl fragment containing the β-lactamase gene was cloned into pLG339 resulting in the recombinant plasmid pZMP1-1. A restriction map of the cloned insert was established and l subfragments of the insert were further subcloned into pBGS18. The nucleotide sequence of the complete 3.6 kb fragment was determined. Within 3663 bp an open reading frame of 858 kb was found to show 99% homology to the SHV-2 and -3 nucleotide sequences. The deduced amino acid sequence differed in one and two positions, respectively, from these established SHV enzymes. The 3′ noncoding sequence exhibited nearly perfect homology to that of SHV-2, but the 5′ upstream sequence showed homology of less than 50% to the corresponding SHV-2 sequence, indicating an altered promoter region of the variant SHV-enzyme. Kinetic analysis of the β-lactamase revealed a 50-100% elevated hydrolytic effectivity on cefotaxime in comparison to other SHV enzymes. Cefoxitin, ceftazidime, aztreonam and imipenem were not hydrolysed by the enzyme. The variant enzyme was inhibited by commonly available β-lactamase inhibitors. Clavulanic acid had the highest affinity for the enzyme and the greatest effectivity in blocking its action. Based on the genetic and kinetic data we propose to classify the enzyme as a new variant β-lactamase of the SHV-type and name it SHV-2a.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-137-3-569
1991-03-01
2021-08-05
Loading full text...

Full text loading...

References

  1. Ambler R. P. 1980; The structure of β-lactamases. Philosophical Transactions of the Royal Society B289:321–331
    [Google Scholar]
  2. Arakawa Y., Ohta M., Kido N., Fujii Y., Komatsu T., & Kato N. 1986; Close evolutionary relationship between the chromosomally encoded β-lactamase gene of Klebsiella pneumoniae and the TEM β-lactamase gene mediated by R plasmids. FEBS Letters 207:69–74
    [Google Scholar]
  3. Arakawa Y., Ohta M., Kido N., Mori M., Ito H., Komatsu T., & Eujii V. 1989; Chromosomal -β-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum β-lactam antibiotics. Antimicrobial Agents and Chemotherapy 33:63–70
    [Google Scholar]
  4. Barthélémy M., Peduzii J., Labia R. 1988a; Complete amino acid sequence of p453-plasmid-mediated PIT-2 β-lactamase (SHV-1). Biochemical Journal 251:73–79
    [Google Scholar]
  5. Barthélémy M., Peduzii J., Yaghlane H. B., Labia R. 1988b; Single amino acid substitution between SHV-l β-lactamase and cefotaxime-hydrolysing SHV-2 enzyme. FEBS Letters 231:217–220
    [Google Scholar]
  6. Birnboim H. C. 1983; A rapid alkaline extraction method for the isolation of plasmid DNA. Methods in Enzymology 100:243–255
    [Google Scholar]
  7. Brooks J. E. 1987; Properties and uses of restriction endonucleases. Methods in Enzymology 152:113–129
    [Google Scholar]
  8. Bure A., Legrand P., Arlet G., Jarlier V., Paul G., Philippon A. 1988; Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. European Journal of Clinical Microbiology 7:780–782
    [Google Scholar]
  9. Bush K., Sykes R. 1986; Methodology for the study of β- lactamases. Antimicrobial Agents and Chemotherapy 30:6–10
    [Google Scholar]
  10. Chen S. T., Clowes R. C. 1984; Two improved promoter sequences for the β-lactamase expression arising from a single base-pair-substitution. Nucleic Acids Research 12:3219–3234
    [Google Scholar]
  11. Dalbadie-McFarland G., Neitzel J. J., Richards J. H. 1986; Active-site mutants of β-lactamase : use of an inactive double mutant to study requirements for catalysis. Biochemistry 2:332–338
    [Google Scholar]
  12. Garbarg-Chenon A., Godard V., Labia R., Nicholas J. C. 1990; Nucleotide sequence of SHV-2 β-lactamase gene. Antimicrobial Agents and Chemotherapy 34:1444–1446
    [Google Scholar]
  13. Gutmann L., Ferré B., Goldstein F. W., Rizk N., Pinto-Schuster E., Acar J. F., Collatz E. 1989; SHV-5, a novel SHV-type β-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrobial Agents and Chemotherapy 33:951–956
    [Google Scholar]
  14. Hanahan D. 1983; Studies on transformation of Escherichia coli with plasmids. Journal of Molecular Biology 166:557–580
    [Google Scholar]
  15. Hawley D. K., McClure W. R. 1983; Compilation and analysis of Escherichia coli promoter DNA sequences. Nucleic Acids Research 11:2237–2255
    [Google Scholar]
  16. Herzberg D., Moult J. 1987; Bacterial resistance to β-Mactam antibiotics: crystal structure of β-Mactamase from Staphylococcus aureus PCI at 2-5 Â resolution. Science 236:694–701
    [Google Scholar]
  17. Jacobs M. R., Aronoff S. C., Johenning S., Shlaes D. M., Yamabe S. 1986; Comparative activities of the β-Mactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad spectrum penicillins against defined β-lactamase-producing aerobic gram-negative bacilli. Antimicrobial Agents and Chemotherapy 29:980–985
    [Google Scholar]
  18. Jarlier V., Nicolas M.H., Fournier G., Philippon A. 1988; Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-Mactam agents in Enterobacteriaceae : hospital prevalence and susceptibility patterns. Reviews of Infectious Diseases 10:867–878
    [Google Scholar]
  19. Krrzis M. D., Billot-Klein D., Goldstein F. W., Williamson R., Tran Van Nhieu G., Carlet J., Acar J. F., Gütmann L. 1988; Dissemination of the novel plasmid-mediated β-Mactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by β-Mactamase inhibitors. Antimicrobial Agents and Chemotherapy 32:9–14
    [Google Scholar]
  20. Kliebe C., Nies B. A., Meyer J. F., Tolxdorff-Neutzling R. M., Wiedemann B. 1985; Evolution of a plasmid-coded resistance to broad spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 28:302–307
    [Google Scholar]
  21. Knothe H., Shah P., Krcmery V., Antal M., Mitsuhashi S. 1983; Transferable resistance to cefotaxime, cefoxitin, sfaman-dole, and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens . Infection 11:315–317
    [Google Scholar]
  22. Labia R., Fabre C., Masson J. M., Barthélémy M, Heitz M., Pitton J. S. 1979; Klebsiella pneumoniae strains moderately resistant to ampicillin and carbenicillin : characterization of a new β-lactamase. Journal of Antimicrobial Chemotherapy 5:375–382
    [Google Scholar]
  23. Labia R., Morand A., Tiwari K., Sirot J. D., Petit A. 1988; Interactions of new plasmid-mediated β-lactamases with third-generation cephalosporins. Reviews of Infectious Diseases 10:885–891
    [Google Scholar]
  24. Mabilat C., Courvalin P. 1990; Development of‘oligotyping’ for characterization and molecular epidemiology of TEM β-lactamases in members of the family Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 34:2210–2216
    [Google Scholar]
  25. Matthew M., Harris A. M., Marshall M. J., Ross G. W. 1975; The use of analytical isoelectric focusing for detection and identification of β-lactamases. Journal of General Microbiology 88:169–178
    [Google Scholar]
  26. Matthew M., Hedges R. W., Smith J. T. 1979; Types of β-lactamase determined by plasmids in gram-negative bacteria. Journal of Bacteriology 138:657–662
    [Google Scholar]
  27. Mercier J., Levesque R. C. 1990; Cloning of SHV-2, OHIO-1, and OXA-6 β-lactamases and cloning and sequencing of SHV-1 β-lactamase. Antimicrobial Agents and Chemotherapy 34:1577–1583
    [Google Scholar]
  28. Nayler J. H. C. 1987; Resistance to β-Mactams in gram-negative bacteria: relative contributions of β-lactamase and permeability limitations. Journal of Antimicrobial Chemotherapy 19:713–732
    [Google Scholar]
  29. Nicolas M. H., Jarlier V., Honore N., Philippon A., Cole S. T. 1989; Molecular characterization of the gene encoding SHV-3 β-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae . Antimicrobial Agents and Chemotherapy 33:2096–2100
    [Google Scholar]
  30. Philippon A., Labia R., Jacoby G. 1989; Extended spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 33:1131–1136
    [Google Scholar]
  31. Pitton J. S. 1972; Mechanisms of bacterial resistance to antibiotics. Reviews in Physiology 65:15–93
    [Google Scholar]
  32. Podbielski A., Melzer B. 1990; Nucleotide sequence of the gene encoding the SHV-2 β-lactamase (bla sHv-2) of Klebsiella ozaenae . Nucleic Acids Research 18:4916
    [Google Scholar]
  33. Podbielski A., Leusch H. G., Berndt R., Haase G. 1988; Analysis of β-lactamase activity and plasmid profile of nosocomial isolates of cefotaxime resistant Klebsiella pneumoniae . Zentralblatt fur Bakteriologie und Hygiene, Series A 268:555
    [Google Scholar]
  34. Podbielski A., Haase G., Berndt R. 1989; An improved broth-microdilution procedure for testing metal ion resistance of Klebsiella pneumoniae . Zentralblatt für Hygiene 189:147–150
    [Google Scholar]
  35. Podbielski A., Leusch H. G., Warnatz K., Melzer B., Haase G. 1990; Characterization of a new Klebsiella pneumoniae SHV-β-lactamase gene responsible for high-level cefotaxime resistance. Zentralblatt für Bakteriologie 273:115
    [Google Scholar]
  36. Podschun R., Heineren P., Ullmann Ü, Sonntag H. G. 1986; Comparative investigations of Klebsiella species of clinical origin: plasmid patterns, biochemical reactions, antibiotic resistance and serotypes. Zentralblatt für Bakteriologie und Hygiene, Series A 262:335–345
    [Google Scholar]
  37. Ross G. W., O’Callaghan C. H. 1975; β-lactamase assays. Methods in Enzymology 47:69–85
    [Google Scholar]
  38. Roy C., Segura C., Tirado M., Reig R., Hermida M., Teruel D., Foz A. 1985; Frequency of plasmid-determined beta-bacta-mases in 680 consecutively isolated strains of Enterobacteriaceae. European Journal of Clinical Microbiology 4:146–147
    [Google Scholar]
  39. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: a Laboratory Manual, 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  40. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain terminating inhibitors. Proceedings of the National Academy of Sciences of the United States of America 745463–5467
    [Google Scholar]
  41. Seeberg A. H., Tolxdorff-Neutzling R. M., Wiedemann B. 1983; Chromosomal β-lactamases of Enterobacter cloacae are responsible for resistance to third generation cephalosporins. Antimicrobial Agents and Chemotherapy 23:918–925
    [Google Scholar]
  42. Selwyn S., Bakhtiar M. 1986; Comparative in vitro studies on cefotaxime and desacetylcefotaxime. Drugs in Experimental and Clinical Research 12:953–965
    [Google Scholar]
  43. Shlaes D. M., Currie-McCumber C, Hull A., Behlau I., Kron M. 1990; OHIO-1 β-lactamase is part of the SHV-1 family. Antimicrobial Agents and Chemotherapy 34:1570–1576
    [Google Scholar]
  44. Spratt B. G., Hedge P. J., te Heesen S., Edelmann A., Broome-Smith J. K. 1986; Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8 and pEMBL9. Gene 41:337–342
    [Google Scholar]
  45. Sougakoff W., Goussard S., Gerbaud G., Courvalin P. 1988a; Plasmid-mediated resistance to third-generation cephalosporins caused by point mutations in TEM-type penicillinase genes. Reviews of Infectious Diseases 10:879–884
    [Google Scholar]
  46. Sougakoff W., Goussard S., Courvalin P. 1988b; The TEM-3 β-lactamase, which hydrolyses broad-spectrum cephalosporins, is derived from the TEM-2 penicillinase by two amino acid substitutions. FEMS Microbiology Letters 56:343–348
    [Google Scholar]
  47. Stoker N. G., Fairweather N. F., Spratt B. 1982; Versatile low-copy-number vectors for cloning in Escherichia coli . Gene 18:335–341
    [Google Scholar]
  48. Waley S. G. 1982; A quick method for the determination of inhibition constants. Biochemical Journal 205:631–633
    [Google Scholar]
  49. Walker J. M. 1984; Methods in Molecular Biology. 2 Nucleic Acids Clifton, NJ: Humana Press;
    [Google Scholar]
  50. Yoshimura F., Nikaido H. 1985; Diffusion of β-lactam antibiotics through the porin channels of Escherichia coli K-12. Antimicrobial Agents and Chemotherapy 27:84–92
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-137-3-569
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error